Fecal microbiota transplantation plus pembrolizumab and axitinib in metastatic renal cell carcinoma: the randomized phase 2 TACITO trial
Università Cattolica del Sacro Cuore · Agostino Gemelli University Polyclinic · +17 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
15
total citations
- FWCI
- 136.98
- Percentile
- 100%
- References
- 64
Too recent for citation history.
Authors
33- SPSerena PorcariCorresponding
Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico
- CCChiara CICCARESE
Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic
- VHVitor Heidrich
University of Trento
- DRDebora Rondinella
Università Cattolica del Sacro Cuore, Agostino Gemelli University Polyclinic, Istituti di Ricovero e Cura a Carattere Scientifico
- GQGianluca Quaranta
Agostino Gemelli University Polyclinic
Topics & keywords
Topics
Keywords
- Clinical endpoint
- Axitinib
- Pembrolizumab
- Hazard ratio
- Renal cell carcinoma
- Placebo
- Peripheral edema
- Transplantation
No related works found for this paper.